This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Judge allows Solodyn pay-for-delay case to go to trial

( January 25, 2018, 15:22 GMT | Official Statement) -- MLex Summary: US District Judge US District Judge Denise J. Casper has denied Impax Laboratories and Medicis Pharmaceutical’s request for summary judgment against direct purchasers’ claims accusing them of conspiring to keep a generic Solodyn off the market. Casper concluded that the issue of circumstantial evidence of market power, along with the question of what is the relevant market, should go to the jury because plaintiffs’ experts have provided quantitative analyses of sales and prices of Solodyn and its supposed competitors. Casper did grant the motion for summary judgment on market power, as to direct evidence only.See document below....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections